Prevalence of polycystic ovary syndrome and related disorders in mexican women

Gynecologic and Obstetric Investigation

Volumn 69, Issue 4, 2010, Pages 274-280

  Moran, Carlos ^a,b   Tena, Gilberto ^a   Moran, Segundo ^b   Ruiz, Paola ^a   Reyna, Rosario ^c   Duque, Ximena ^b  

^a Medical Unit of High Specialty in Gynecology and Obstetrics No 4 Luis Castelazo Ayala   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Hyperandrogenism; Menstrual cycle; Polycystic ovary syndrome; Ultrasonography

Indexed keywords

ANDROGEN;

ACNE; ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; DISEASE CLASSIFICATION; ECHOGRAPHY; FEMALE; HIRSUTISM; HISPANIC; HUMAN; HYPERANDROGENISM; MENSTRUAL CYCLE; MEXICO; OLIGOOVULATION; OVARY INSUFFICIENCY; OVARY POLYCYSTIC DISEASE; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; TRANSABDOMINAL ECHOGRAPHY; TRANSVAGINAL ECHOGRAPHY; WOMEN'S HEALTH;

ACNE VULGARIS; ADULT; ANDROGENS; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FEMALE; HIRSUTISM; HUMANS; HYPERANDROGENISM; MEXICAN AMERICANS; MEXICO; MIDDLE AGED; OVARY; OVULATION; POLYCYSTIC OVARY SYNDROME; PROSPECTIVE STUDIES; UNITED STATES;

EID: 75149149933     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000277640     Document Type: Article

References (34)

1. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R: Prevalence of the polycystic ovary syndrome in unselected Black and White women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998; 83: 3078-3082.
2. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI: A survey of the polycystic ovary syndrome in the Greek Island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999; 84: 4006-4011.
3. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF: A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000; 85: 2434-2438.
4. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO: The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004; 89: 2745-2749.
5. Moran C, Tapia MC, Hernandez E, Vazquez G, Garcia Hernandez E, Bermudez JA: Etiological review of hirsutism in 250 patients. Arch Med Res 1994; 25: 311-314.
6. Azziz R, Sanchez LA, Knochenhauer ES, Moran C, Lazenby J, Stephens KC, Taylor K, Boots LR: Androgen excess in women: experience with over 1,000 consecutive patients. J Clin Endocrinol Metab 2004; 89: 453-462.
7. Carmina E, Rosato F, Janni A, Rizzo M, Longo RA: Relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. J Clin Endocrinol Metab 2006; 91: 2-6.
8. Goodarzi MO, Quiñones MJ, Azziz R, Rotter JI, Hsueh WA, Yang H: Polycysytic ovary syndrome in Mexican-Americans: prevalence and association with the severity of insulin resistance. Fertil Steril 2005; 84: 766-769. (Pubitemid 41317746)
9. Zawadzki JK, Dunaif A: Diagnostic criteria for polycystic ovary syndrome: towards a rational approach; in Dunaif A, Givens JR, Haseltine F, Merriam GR (eds): Polycystic Ovary Syndrome. Boston, Blackwell, 1992, pp 377-384.
10. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81: 19-24.
11. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF: The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 2009; 91: 456-488.
12. Legro RS, Kunselman AR, Dodson WC, Dunaif A: Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 1999; 84: 165-169.
13. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J: Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999; 22: 141-146.
14. WHO Expert Committee: Physical Status: The Use and Interpretation of Anthropometry. WHO Tec Rep Ser No. 854. Geneva, WHO, 1995.
15. Moran C, Hernandez E, Ruiz JE, Fonseca ME, Bermudez JA, Zarate A: Upper body obesity and hyperinsulinemia are associated with anovulation. Gynecol Obstet Invest 1999; 47: 1-5.
16. Ferriman D, Gallwey JD: Clinical assessment of body hair growth in women. J Clin Endocr 1961; 21: 1440-1447.
17. Hatch R, Rosenfield RL, Kim MH, Tredway D: Hirsutism: implications, etiology, and management. Am J Obstet Gynecol 1981; 140: 815-830.
18. Whitley E, Ball J: Statistics review 2: samples and populations. Crit Care 2002; 6: 143-148.
19. Bland JM, Altman DG: Transforming data. Statistics notes. BMJ 1996; 312: 770.
20. Moran C, Azziz R, Weintrob N, Witchel S, Rohmer V, Dewailly D, Marcondes JAM, Pugeat M, Speiser PW, Pignatelli D, Mendonca BB, Bachega TAS, Escobar-Morreale HF, Carmina E, Fruzzetti F, Kelestimur F: Reproductive outcome of women with 21- hydroxylase deficient nonclassic adrenal hyperplasia. J Clin Endocrinol Metab 2006; 91: 3451-3456.
21. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2008; 31:S62-S67.
22. Legro RS, Castracane VD, Kauffman RP: Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv 2004; 59: 141-154.
23. Dewailly D: The role of pelvic sonography in the polycystic ovary syndrome. Androgen Excess Soc Bull 2005; 3: 1-4.
24. Polson DW, Adams J, Wadsworth J, Franks S: Polycystic ovaries: a common finding in normal women. Lancet 1988;i:870-872.
25. Koivunen R, Laatikainen T, Tomas C, Huhtaniemi I, Tapanainen J, Martikainen H: The prevalence of polycystic ovaries in healthy women. Acta Obstet Gynecol Scand 1999; 78: 137-141.
26. Farquhar CM, Birdsall M, Manning P, Mitchell JM, France JT: The prevalence of polycystic ovaries on ultrasound scanning on a population of randomly selected women. Aust NZ J Obstet Gynecol 1994; 34: 67-72.
27. Romaguera J, Moran C, Diaz-Montes TP, Hines GA, Cruz RI, Azzis R: Prevalence of 21-hydroxylase-deficient nonclassic adrenal hyperplasia and insulin resistance among hirsute women from Puerto Rico. Fertil Steril 2000; 74: 59-62.
28. Rivolta G, Cerutti R, Colombo R, Miano G, Dionisio P, Grossi E: Prevalence of subclinical hypothyroidism in a population living in the Milan metropolitan area. J Endocrinol Invest 1999;22: 693-697.
29. Hollowell JG, Staehling NW, Flanders WD, Hannon WH, Gunter EW, Spencer CA, Braverman LE: Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87: 489-499.
30. Josimovich JB, Lavenhar MA, Devanesan MM, Sesta HJ, Wilchins SA, Smith AC: Heterogeneous distribution of serum prolactin values in apparently healthy young women, and the effects of oral contraceptive medication. Fertil Steril 1987; 47: 785-791.
31. Biller BM, Luciano A, Crosignani PG, Molitch M, Olive D, Rebar R, Sanfilippo J, Webster J, Zacur H: Guidelines for the diagnosis and treatment of hyperprolactinemia. J Reprod Med 1999; 44(suppl 12):1075-1084.
32. Kauffman RP, Baker VM, DiMarino P, Gimpel T, Castracane VD: Polycystic ovarian syndrome and insulin resistance in White and Mexican American women: a comparison of two distinct populations. Am J Obstet Gynecol 2002; 187: 1362-1369.
33. Secretaría de Salud: Encuesta Nacional de Enfermedades Crónicas. México, 1993. Diabetes mellitus. Cap. 3, pág. 10-15.
34. Olaiz-Fernandez G, Rojas R, Aguilar-Salinas CA, Rauda J, Villalpando S: Diabetes mellitus in Mexican adults: results from the 2000 National Health Survey. Salud Publica Mex 2007; 49(suppl 3):s331-s337.